Regenicin Inc RGIN

Healthcare Biotechnology

Regenicin, Inc. is a biotechnology company that is focused on the development of regenerative cell therapies to restore the health of damaged tissues and organs. The Company is focused on developing and commercializing a lifesaving technology through the introduction of tissue-engineered skin substitutes to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds and a range of plastic surgery procedures. Its product, NovaDerm, is a multi-layered tissue-engineered skin prepared by utilizing autologous skin cells. NovaDerm is a graftable cultured epithelium skin substitute containing both epidermal and dermal components. It is focused on developing its product, TempaDerm. TempaDerm cells develop banks of cryo-preserved (frozen) cells and cultured skin substitutes to provide a continuous supply of non-allogenic skin substitutes to treat smaller wound areas in patients, such as ulcers. Its application is used for the treatment of chronic skin wounds.

GREY:RGIN - Post by User

Regenicin Inc

Bullboard Posts

Next >>

Post by equityman33on Jun 07, 2011 12:38pm

295 Views

Post# 18681486

PermaDermâ„¢ technology used on more than 150 pedi

Regenicin, Inc. is currently working with their contract manufacturer toprepare for pre-market approval of PermaDerm™ from the FDA. PermaDerm™shows promise to save lives, reduce healthcare costs by decreasing apatient’s stay in the Critical Care Unit and reduce the need foradditional surgeries.

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle